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Abstract
The functions of actin family members during development are poorly understood. To investigate the role of beta-actin in
mammalian development, a beta-actin knockout mouse model was used. Homozygous beta-actin knockout mice are lethal
at embryonic day (E)10.5. At E10.25 beta-actin knockout embryos are growth retarded and display a pale yolk sac and
embryo proper that is suggestive of altered erythropoiesis. Here we report that lack of beta-actin resulted in a block of
primitive and definitive hematopoietic development. Reduced levels of Gata2, were associated to this phenotype.
Consistently, ChIP analysis revealed multiple binding sites for beta-actin in the Gata2 promoter. Gata2 mRNA levels were
almost completely rescued by expression of an erythroid lineage restricted ROSA26-promotor based GATA2 transgene. As a
result, erythroid differentiation was restored and the knockout embryos showed significant improvement in yolk sac and
embryo vascularization. These results provide new molecular insights for a novel function of beta-actin in erythropoiesis by
modulating the expression levels of Gata2 in vivo.
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Introduction
Actins are highly conserved proteins among various species
throughout evolution [1]. The human genome has multiple
functional actin genes and more than twenty pseudogenes [2,3].
The expression patterns of vertebrate actins are temporally and
spatially regulated during development and in the adult organism,
suggesting different isoform specific functions [1,4]. The four
muscle-specific actins provide strength and contractility to muscle
cells. By contrast beta- and gamma-cytoplasmic actins (further
referred to as beta- and gamma-actin), that are coexpressed in all
adult non-muscle tissues [5] are thought to participate in more
dynamic actin cytoskeletal processes. Whereas gamma-actin seems
to be uniformly distributed in all actin-containing structures, beta-
actin seems to have a more polarized distribution, localized to the
cortex of cells, specifically functioning in protrusive structures such
as lamellipodia and filopodia [6,7,8,9].
In more recent cell work, actin was found localized in the
nucleus leading to the hypothesis that beta-actin could be
implicated in modulating transcriptional activity. Actin interacts
with all three RNA polymerases and beta-actin has been identified
as a component of different types of chromatin remodeling
complexes in a wide range of organisms [10]. In addition,
antibodies against beta-actin block transcription [11] and nuclear
translocation of beta-actin is involved in macrophage differenti-
ation [12]. Although these previous studies obviously demonstrate
a role for beta-actin in the nucleus, it is not clear if subsets of genes
are dependent on beta-actin function in the nucleus and whether
such mechanisms are important in instructing developmental
processes.
A wealth of information regarding function and localization of
actin isoforms was obtained from in vitro and ex vitro work, but
studies on their role in vivo and in particular during mouse
development, are lagging behind [13,14]. The alpha-skeletal
muscle actin knockout mouse and the alpha-cardiac muscle actin
knockout mouse die, respectively, postnatally and perinatally due
to muscle weakness [15,16]. The alpha-smooth muscle actin
knockout mice are viable but display cardiovascular defects [17].
Most gamma-actin knockout mice die within 48 hours after birth
due to respiratory failure [18]. Mice that survive display
progressive hearing loss. The embryonic lethality of the beta-actin
knockout mice at E10.5, in spite of compensatory upregulation of
other actins, suggests a lack of redundancy of actin functions at this
stage in development [19]. In view of these observations, the
functions of the cytoplasmic actins, and in particular of beta-actin,
during development have remained poorly understood.
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To contribute to knowledge on the function of beta-actin during
mouse development we further investigated the possible causes of
this early embryonic lethality by employing a heterozygous beta-
actin knockout mouse that was previously generated (Actb+/2) [19].
We observed a diminished number of primitive erythroid cells and
a paucity of well-organized blood islands that are the initial sites of
primitive erythroid and endothelial cell development. We show
that ablation of beta-actin expression during development
interferes with red blood cell (RBC) development, resulting in
reduced amounts of primitive and definitive erythroid cells in the
Actb2/2 embryos. Most strikingly, mRNA expression levels of
Gata2, a transcription factor involved in early hematopoiesis, was
dramatically decreased in yolk sacs of E8.5 Actb2/2 embryos.
Corroborating a role for beta-actin in Gata2 regulation, we could
show association of the beta-actin protein to the Gata2 promoter.
Further confirming a developmental link between beta-actin
function and Gata2 regulation, transgenic expression of Gata2
specifically within the erythroid lineage in these Actb2/2 embryos
partially rescued the observed phenotypes. Our findings therefore
support a novel function of beta-actin in modulating erythropoiesis
by fine-tuning Gata2 levels in the early developing mouse embryo.
Materials and Methods
Ethics Statement
The animal ethics committee of Ghent University approved all
experiments performed on mice. Approval number ECD10/29.
Mice
The generation of the Actb+/2 mice has been previously
described [19]. Actb+/2 mice were crossed to generate control
Actb+/+ embryos and Actb2/2 embryos. Genotyping was done by
fluorescent microscopy (positive for Actb+/2 and Actb2/2) followed
by western blotting with an antibody against beta-actin (to
distinguish Actb+/2 and Actb2/2). Mice were kept on an inbred
BALB/c background. Actb+/2 mice were crossed with Flk1-LacZ
mice [20] to generate double heterozygous knockouts. Genotyping
was done by fluorescent microscopy followed by a LacZ PCR.
Actb+/2 mice were crossed with EpoR-iCreTg/+ [21] mice and with
ROSA26-hGata2Tg/Tg [21] to generate the Actb2/2 R26+hGa-
ta2EpoR-iCre/+ rescue mice. Genotyping was done by fluorescent
microscopy followed by PCR.
Antibodies
Antibodies (Ab) used in this study are rat-anti-mouse PECAM-1
mAb (Clone CD31), biotin-conjugated rat-anti-mouse PECAM-1
mAb (clone CD31) and biotin-conjugated goat-anti-rat Ig specific
pAb, all from BD Pharmingen. ABC reagent (Vector Labs) was
used with the biotin-conjugated CD31 mAb, whereas the
Renaissance TSA Biotin System (PerkinElmer Life Sciences) was
used with the other Abs. Anti beta-actin mAb (clone AC-15), from
Sigma. Anti gamma-cytoplasmic actin pAb, from Millipore. Anti
gata2 pAb, from Abcam.
Paraffin histology
Dissected samples were fixed overnight in 4% paraformalde-
hyde at 4uC, processed for paraffin embedding, and sectioned at
6 mm. Sections were stained with hematoxylin and eosin (H&E).
Additional paraffin sections were used for immunohistochemistry
and immunofluorescence.
Immunohistochemistry
Immunohistochemistry on whole mount embryos was per-
formed as previously described [22]. Briefly, embryos were fixed in
MeOH:DMSO (4:1) overnight at 4uC, treated with MeOH:DM-
SO:H2O2 (4:1:1) for 5–10 hours at room temperature to block
endogenous peroxidase activity and stored in methanol at 220uC.
The embryos were subsequently rehydrated in 50% MeOH in
phosphate buffered saline PBS and incubated with the primary
antibody in 3% instant skim milk powder/0.1% Triton X-100 in
PBS (PBSMT) overnight at 4uC. Following washes in PBSMT for
5 hours at room temperature, embryos were incubated with the
ABC reagent, in PBSMT overnight at 4uC. Following washes in
PBSMT for 5 hours at room temperature and brief washes with
PBS with 0.1% Triton X-100, the embryos were developed with
3.3-diaminobenzidine tetrahydrochloride (DAB) (Vector laborato-
ries). The reaction was stopped by fixing the embryos in 4% PFA
in PBS at room temperature for 1 hour. Immunohistochemistry
on paraffin sections was done according to the protocol of the
Renaissance TSA Biotin System (NEL 700, PerkinElmer). LacZ
stainings were done according to manufacturer protocols (Milli-
pore).
Immunofluorescence
Immunofluorescence on paraffin sections started by deparaffi-
nization through ethanol series. Sections were microwaved in
0,01 M citrate buffer (pH 6.0) for 15 min at full power and
washed in PBS. Sections were blocked in 10% goat serum/1%
BSA in PBS for 1 hour at room temperature and incubated with
primary antibody in blocking solution overnight at 4uC. Following
four washes with PBS of each 30 min at room temperature,
sections were incubated with secondary antibody for 2 hours at
room temperature. Following four washes with PBS of each
15 min at room temperature, nuclei of cells were stained with
DAPI and sections were mounted with DABCO mounting
medium (Sigma-Aldrich).
Molecular analysis
Yolk Sacs (YS) were dissected at E8.5 and E10.25, or in case of
Actb2/2 R26+hGata2EpoR-iCre/+ at E10.25 and E11.5, flash-frozen
in liquid nitrogen, and processed according to standard protocols.
RNA was extracted with High Pure RNA isolation kit (Roche) and
precipitated overnight at 280uC or 1 hr on dry ice. cDNA was
synthesized with the transcriptor first strand cDNA synthesis kit
(Roche). Quantitative reverse-transcription-polymerase chain re-
action (qRT-PCR) was performed on a LightCycler 480 system
(Roche) using the SYBR Green Master kit (Roche). Gene
expression was normalized using glyceraldehyde 3-phosphate
dehydrogenase (Gapdh), ubiquitine C (Ubc), glucose-6-phosphate
dehydrogenase, (G6pdh) and hypoxanthin phosphoribosyl transfer-
ase 1 (Hprt1) as controls. Primers used are given in Table S1. The
expression levels of each gene are reported relative to those
observed in Actb+/+ control samples. For sampling and statistics see
below.
ChIP
Bone marrow cells were cross-linked in 1% formaldehyde for 10
minutes at room temperature and the reaction was stopped with
glycine (final concentration 0,125 M). Cells were lysed in the
presence of protease inhibitors and DNA was sonicated. For each
immunoprecipitation, 100 mg DNA was used together with 3 ml of
anti beta-actin mAb (clone AC-15, Sigma) or anti gamma-
cytoplasmic actin pAb (Millipore). Complexes were precipitated
with protein A and G Sepharose beads (GE Healthcare).
Formaldehyde cross-links were reversed by overnight incubation
at 65uC and DNA was purified using QIAquick PCR Purification
Kit (Qiagen). Matinspector was used to analyse amplicons for
DNA core consensus sites. Primers used are given in Table S2,
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including localization of the respectively amplicons on the Gata2
promotor.
In vitro hematopoietic progenitor assays
For primitive erythroid (EryP) colony assays were performed on
stage matched E8.5 whole embryos as previously described [21].
Definitive erythroid colony assays were performed on E9.75 yolk
sacs as previously described [21] using 1% methylcellulose
(StemCell Technologies) containing complete recombinant cyto-
kines (MethoCult GF M3434) for the detection and quantification
of burst forming unit-erythroid cells (BFU-E), colony forming unit-
granulocyte/macrophage (CFU-GM) and colony forming unit-
granulocyte/erythrocyte/monocyte/megakaryocyte (CFU-
GEMM). After 7 days colonies were scored under a microscope.
The results are expressed as a percentage of absolute number of
colonies per yolk sac of the Actb+/+ controls.
Imaging
Embryos were imaged on a Leica MS5 (Leica Microsystems)
stereomicroscope. Digital images were acquired using a Leica
camera. Section H&E staining and immunohistochemistry were
imaged using a SNAP-COOL camera (Roper Scientific) mounted
on an Olympus Bx51 microscope (Olympus), with Plan Olympus
206/0.40 or 406/0.65 lens and RSImage Version 1.9.2 software
(Roper Scientific).
Figure 1. Actb2/2 embryos are pale and growth retarded at E10.25. (A) Pictures of freshly dissected embryos at E10.25. Pale and growth
retarded Actb2/2 embryos show no obvious vascular pattern in the embryo proper (middle) or yolk sac (right) compared to the Actb+/+ littermates.
156magnification. (B) LacZ stainings of Actb+/+ and Actb2/2 yolk sac at E9.5 indicate reduced vascular branching complexity of Actb2/2 yolk sacs.
206magnification. (C) Whole mount PECAM-1 immunohistochemistry of Actb+/+ and Actb2/2 embryos, processed in parallel, shows less coloring,
indicating fewer endothelial cells and red blood cells. 156 magnification. Embryos were imaged on a Leica MS5 (Leica Microsystems)
stereomicroscope. Digital images were acquired using a Leica camera.
doi:10.1371/journal.pone.0067855.g001
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Statistical analysis
Data were expressed as mean plus or minus SEM. Comparison
between 2 data groups was done by the 2-sided Student t test. A
minimum of three biological replicates was used in each condition
for each genotype. Two technical replicates were used per
biological replicate.
Results
Yolk sac blood island development is affected in beta-
actin knockout embryos
To specifically address the role of beta-actin in development, a
beta-actin knockout mouse allele was used (Actb+/2). It was
previously shown that the homozygous beta-actin knockout mice
(Actb2/2) are lethal at E10.5 [19], however the exact cause of
lethality has not been investigated. At E8.5, no obvious
morphological differences between Actb+/+ and Actb2/2 embryos
could be observed (data not shown). One day later at E9.5 Actb2/2
embryos have an appropriate number of somites and were in that
aspect comparable in development to Actb+/+ littermates. Howev-
er, the Actb2/2 embryos display a visibly pale yolk sac and embryo
proper (Figure 1A). Yolk sacs of Actb+/+ embryos displayed large
RBC containing vessels, whereas no such vessels could be observed
in Actb2/2 yolk sacs. (Figure 1A). To study the branching pattern
of the vasculature in the yolk sac, Actb+/2 mice were crossed with
Flk1-LacZ mice [20]. Flk1 marks vascular and hematopoietic
progenitors and the Flk1-LacZ mice express a LacZ reporter under
control of the Flk1 promotor. It is therefore possible to monitor the
migration of hemangioblast progenitors from the primitive streak
towards the yolk sac and to study the vasculogenesis process. The
resulting E9.5 Actb2/2 Flk1-LacZ embryos displayed clearly
reduced vascular branching complexity in the yolk sac and
specifically in the head region of the embryo proper compared to
the Actb+/+ Flk1-LacZ littermates (Figure 1B). Especially the
remodeled large branched vessels, which are already prominent in
yolk sacs of Actb+/+ Flk1-LacZ embryos seemed to be absent in the
Actb2/2 Flk1-LacZ embryos. Rather the Actb2/2 yolk sacs still
contained the honeycomb-shaped capillary plexus (typical for E8.5
embryos), which did not reorganize into large branches, suggesting
a block in proper vasculo/angiogenesis development.
At E10.25, the Actb2/2 embryos were morphologically growth
retarded. In view of the impaired vascular development of the yolk
sac at E9.5 we performed PECAM-1 whole mount immunostain-
ing at E10.25 embryos. This analysis showed the presence of a
more weakly stained vasculature and therefore suggests diminished
numbers of endothelial cells in Actb2/2 embryos, similar to the
yolk sac vascular defects (Figure 1C). PECAM-1 immunostaining
on sections from E9.5 embryos demonstrated normal endocardial
and slightly abnormal intersomitic vessel development (Figure 2A
and data not shown).
More detailed analysis of yolk sacs of Actb2/2 embryos at E9.5
revealed enlarged blood islands harboring fewer RBCs compared
to wild type Actb+/+ yolk sacs (Figure 2B). At E10.25, routine H&E
staining and PECAM-1 immunohistochemistry revealed abnormal
vessel morphology and endothelial patterning in Actb2/2 yolk sacs
(Figure 2C-D). We conclude that blood island morphology is
largely impaired.
Absence of beta-actin modulates yolk sac erythropoiesis
As the embryo becomes larger, diffusion of oxygen is no longer
sufficient at E9.5. To accommodate the embryo proper with
sufficient oxygen, primitive erythropoiesis takes place before this
stage, enabling the production of a temporary wave of primitive
RBCs in the blood islands of the yolk sac. In view of the pale yolk
sacs of Actb2/2 embryos, suggesting reduced numbers of primitive
RBCs, we investigated if primitive erythropoiesis was affected.
Although there was no difference in the morphology of erythroid
progenitor (EryP) colonies, the number of colonies derived from
E8.5 Actb2/2 embryos was decreased by more than 90%
compared to Actb+/+ embryos (Figure 3A), a result that is
consistent with the low amount of RBCs observed in freshly
dissected embryos and sections (Figure 1–2).
The initial phase of primitive erythropoiesis is succeeded by
definitive embryonic erythropoiesis, and therefore we also
quantified definitive erythroid progenitors in vitro. Methylcellulose
assays conducted on E9.75 yolk sacs showed an 85% decrease of
BFU-E and 90% decrease of CFU-GM and CFU-GEMM colony
numbers in Actb2/2 embryos (Figure 3B). Again, the colonies
formed in methylcellulose did not morphologically differ from the
colonies of Actb+/+ littermates. These results demonstrate that
absence of beta-actin has negative effects on embryonic hemato-
poiesis.
Absence of primitive erythropoiesis in Actb2/2 embryos
correlates with reduced Gata2 expression
To correlate these effects on embryonic erythropoiesis in the
Actb2/2 embryos with molecular alterations of known transcrip-
tional modulators that play important roles in erythropoiesis, we
performed qRT-PCR mRNA expression analysis on Actb2/2
versus Actb+/+ yolk sacs for key erythroid transcription factors
Gata1 and Gata2. Since separation of endothelial and hematopoi-
etic cells from yolk sacs of this stage is technically extremely
challenging, we used the whole yolk sac. We also tested the
embryonic globins Hbb-y and Hbb-bh1 and the adult globins Hba
and Hbb. At E8.5, no morphological differences could be
observed between Actb2/2 and Actb+/+ embryos. We found no
significant changes for Gata1 and Hbb. Hba gave a slight but
significant reduction (Figure 4A). However, the most dramatic
effects were seen for Gata2, Hbb-y and Hbb-bh1 expression. Gata2
was decreased by 90% and Hbb-y and Hbb-bh1 expression levels
were decreased by respectively 75% and 70% (Figure 4A). This
further corroborates the negative effects of beta-actin depletion on
primitive erythropoiesis observed in our methylcellulose experi-
ments. Our results regarding the observed decrease in primitive
hematopoiesis in the Actb2/2 embryo are consistent with the
observed anemia and lethality at E10.5 in Gata2 knockout embryos
[23] indicating that the diminished expression of Gata2 contributes
to this phenotype in the Actb2/2 embryos.
We also quantified target genes of Gata2 at E8.5: Runx1, Tal/Scl,
c-kit, EpoR, Hhex and Lmo2 (Figure 4B). In none of the genotypes
we detected expression of Hhex and Lmo2 at this developmental
stage (data not shown). Runx1 and Tal/Scl expression levels gave
no significant differences but c-kit and EpoR were downregulated
by more than 50% in Actb2/2 yolk sacs, further emphasizing the
consequences of Gata2 downregulation in the Actb2/2 embryos.
Gata2 is also expressed in the vascular endothelium of the
embryo proper [24]. To differentiate between the remodeling
defects of yolk sac blood vessels versus the impaired erythropoiesis,
we studied the expression of GATA2 protein in the blood islands
at E9.5. In the Actb+/+ embryos GATA2 protein is expressed in
primitive erythrocytes and to a moderate extent in the yolk sac
endoderm. However, no GATA2 expression could be seen in the
vascular endothelial cells of the yolk sac. Importantly, we could not
detect a difference between GATA2 expression in the endoderm
nor in the vascular endothelial cells of Actb2/2 versus the Actb+/+
yolk sacs, suggesting that the vascular remodeling defect is not
caused by a differential expression of GATA2 (Figure 4C), but
rather by an impaired blood flow and/or increased hypoxia due to
Absence of Beta-Actin Modulates Erythropoiesis
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lack of erythroid differentiation. Indeed, we also tested Vegf
expression levels in the yolk sac at E8.5 and E10.25 (Figure 4D). At
E10.25, Vegf mRNA levels are more than 50% higher in Actb2/2
yolk sacs versus Actb+/+ yolk sacs, suggesting hypoxic conditions in
the embryos. Moreover, the Gata2 target gene Tal/Scl, involved in
the development of the vascular endothelium [24], shows no
difference in expression between Actb+/+ and Actb2/2 yolk sacs
(Figure 4B), further supporting the hypothesis that impaired blood
flow or hypoxic insult arising due to a lack of erythropoiesis is
causing the vascular remodeling defects.
Compensatory up regulation of gamma-actin does not
prevent lethality
In Actb2/2 embryos as well as in Actb2/2 mouse embryonic
fibroblasts (MEFs) and T-cells, gamma-actin, the second cytoplas-
mic isoform, is upregulated [13,18]. To investigate whether this is
also the case in Actb2/2 yolk sacs we compared gamma-actin
expression levels with Actb+/+ control yolk sacs by qRT-PCR and
Western blot analysis. At E8.5, there is an approximate two-fold
increase of gamma-actin mRNA expression and only a slight
increase of gamma-actin protein in the Actb2/2 versus Actb+/+ yolk
sacs (Fig S1A–B). At E10.25, gamma-actin mRNA expression
patterns remained doubled and the gamma-actin protein levels
were increased compared to the E8.5 timepoint (Fig S1A–C). In
view of the observation that gamma-actin is the dominant isoform
during mouse organogenesis (Fig S1D), this continuing compen-
satory expression of gamma-actin in the Actb2/2 yolk sac is
apparently not capable of rescuing the hematopoietic related
phenotypes and indicates that the functions of both cytoplasmic
isoforms are in this process non redundant.
Beta-actin linked to several regions of the Gata2 gene
To begin determining the molecular basis linking beta-actin to
Gata2 expression, we performed ChIP analysis. Since it is
technically impossible to obtain enough hematopoietic cells from
these embryos to perform ChIP experiments, we isolated bone
marrow cells from wild type mice. We used 9 primer sets covering
3 kbp of the Gata2 promotor region. As shown in Figure 5A,
immunoprecipitation with the anti beta-actin antibody followed by
qRT-PCR with specific primers for the Gata2 promotor region
yielded two loci of interest (amplicon 3 and 8, Figure 5A),
indicating that beta-actin binds directly or indirectly to the Gata2
promotor. In contrast, immunoprecipitation with an antibody
against gamma-actin did not yield any amplicon signal, indicating
Figure 2. Actb2/2 embryos show reduced number of red blood cells and abnormal blood island morphology in the yolk sac. (A)
PECAM-1 immunostained sagittal cardiac and somitic section, showing normal development of the left atrium (a), atrioventricular canal (av), left
ventricle (v) and regular development of intersomitic vessels. (B) H&E stained yolk sac sections show disrupted blood island morphology with empty,
enlarged cavities in E9.5 Actb2/2 embryos. A and B at 206magnification. (C) H&E stained yolk sac sections show an almost complete absence of
blood islands in E10.25 Actb2/2 embryos. 406 magnification. (D) PECAM-1 immunostained yolk sac section showing disorganized endothelial
patterning and almost no red blood cells populating the remaining blood islands at E10.25. C and D at 406magnification. Sections were imaged
using a SNAP-COOL camera (Roper Scientific) mounted on an Olympus Bx51 microscope (Olympus), with Plan Olympus 206/0.40 or 406/0.65 lens
and RSImage Version 1.9.2 software (Roper Scientific).
doi:10.1371/journal.pone.0067855.g002
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Figure 3. Yolk sac erythropoiesis is impaired in Actb2/2 embryos. (A) Primitive erythroid colonies (EryP) from E8.5 yolk sacs measured by
methylcellulose assays show a dramatic decrease in colony forming potential in Actb2/2 embryos compared to Actb+/+ embryos. Results are given as
percentage of Actb+/+ embryos absolute number of colonies (100%). (B) Definitive erythroid colonies (BFU-E, CFU-GM and CFU-GEMM) from E9.75 yolk
sacs measured by methylcellulose assays show an 85 to 90% decrease in colony forming potential of Actb2/2 embryos versus Actb+/+ embryos.
Results are given as percentage of Actb+/+ embryos absolute number of colonies (100%). Bars represent mean 6SEM; *P,.05, **P,.01, ***P,.001.
doi:10.1371/journal.pone.0067855.g003
Figure 4. Absence of beta-actin during primitive erythropoiesis correlates with reduced Gata2 expression levels in the yolk sac. (A)
Relative E8.5 yolk sac mRNA levels measured by qRT-PCR of Gata1, Gata2, Hbb-y, Hbb-bh1, Hba and Hbb. We found a 90% decrease of Gata2
expression level in Actb2/2 embryos versus Actb+/+ embryos. (B) Relative E8.5 yolk sac mRNA levels measured by qRT-PCR of Gata2 target genes:
Runx1, Tal1/Scl, c-kit and EpoR. c-kit and EpoR show 50% reduced expression levels in Actb2/2 embryos versus Actb+/+ embryos. (C) Gata2
immunohistochemistry on E9.5 yolk sac sections. Gata2 expression was detected only in the endoderm of the yolk sac (white arrows). No difference in
Gata2 expression could be seen between Actb2/2 embryos and Actb+/+ embryos. 606magnification. (D) Relative E8.5 and E10.25 yolk sac mRNA
levels measured by qRT-PCR of Vegf. At E10.25, we could demonstrate a 50% increase of Vegf mRNA expression. Error bars represent mean 6SEM;
*P,.05. Immunofluorescence sections were imaged using an Olympus IX81 confocal microscope with Fluoview FV10 software.
doi:10.1371/journal.pone.0067855.g004
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that beta-actin specifically binds to these regions of the Gata2
promotor.
Genomic alignment of these amplicon sequences using BLAT
(http://genome.ucsc.edu/) indicated that amplicon 3 is partly
overlapping with a highly conserved region within the Gata2
promotor (Figure 5B). The fact that this domain is highly
conserved during mammalian evolution suggest that it may
contain important regulatory binding sites that control Gata2
transcription. Therefore, we screened the amplicon 3 sequence as
well as flanking sequences for putative core consensus binding sites
of transcription factors playing key roles in hematopoiesis and
blood island formation. Multiple DNA core consensus sites were
found (Figure S2) such as target binding sequences for Runx1,
Hhex, Szf1, Mzf1 and Tal/Scl [25,26,27,28] transcription factors
with a role in hematopoiesis. Contained within these conserved
sequences we also found binding sites for the CP2, Klf1 (Eklf) and
Zbp-89 transcription factors that are specifically involved in the
regulation and/or maturation of erythroid progenitors [29,30,31].
Other putative sites found within these regions are for transcrip-
tion factors that are downstream effectors of multiple signaling
pathways (NF-kB and c-Rel) [32], functioning in hypoxia signaling
cascades (Hif-1) [33] or functioning as chromatin organizers (Ctcf)
[34]. Interestingly, we also identified a site for ZF161 (ZF5), an
activator or repressor of transcription that was shown to repress
the Actb promotor [35]. Amplicon 8 harbors a reverse CCAAT
box, the consensus sequence for the maternal CCAAT box
transcription factor, specifically necessary for full promotor activity
of the Gata2 gene [36].
Erythroid restricted ROSA26-promoter based expression
of Gata2 partially rescues erythropoiesis block of Actb2/2
embryos
To further confirm the functional involvement of decreased
Gata2 levels in the erythropoiesis block in Actb2/2 embryos and
to demonstrate that the vascular defects are secondary to this
block in erythroid differentiation we attempted to rescue the
lethality using erythroid lineage restricted expression of a
ROSA26-promoter based transgenic expression of human
Gata2 (hGata2). The erythroid lineage restricted expression of
Gata2 was previous described in literature [21,37]. We
generated EpoR-iCreTg/+, ROSA26-hGata2Tg/+, Actb2/2 embryos
Figure 5. Beta-actin binds to specific regions of the Gata2 gene. (A) Immunoprecipitation with the anti beta-actin and anti gamma-actin
antibodies followed by qRT-PCR with 9 specific primers for the Gata2 promotor region yielded 2 loci of interest: amplicon 3 and 8. Error bars
represent mean 6SEM; *P,.05, **P,.01. (B) Genomic alignment with multiple species showing that amplicon 3 is partly overlapping with a highly
conserved region in the Gata2 promotor, especially in mammals. Also the localization of the specific amplicons relative to the mouse Gata2 gene is
shown. Amplicon8 is located between exons 1 and 2. Figure was made using UCSC genome bioinformatics software (http://genome.ucsc.edu/).
doi:10.1371/journal.pone.0067855.g005
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(Actb2/2 R26+hGata2EpoR-iCre/+, breeding scheme in Figure 6A).
Unlike their Actb2/2 embryo littermates we could obtain viable
normal looking Actb2/2 R26+hGata2EpoR-iCre/+ embryos until
E11.5, providing strong genetic evidence that erythroid-restricted
transgene expression of Gata2 is capable of rescuing the lethality of
the Actb2/2 embryos at E10.5. However, despite this partial rescue
all Actb2/2R26+hGata2EpoR-iCre/+ embryos were not surviving past
E12.5 (Figure 6B). Percentages of surviving embryos are summa-
rized in Table S3. Figure 6B clearly illustrates that Actb2/2
R26+hGata2EpoR-iCre/+ embryos passed the primitive erythropoiesis
phase and show prominent RBCs filled blood vessels at E11.5. We
observed some heterogeneity in the rescue abilities of the embryos at
E11.5 (Figure 6C). However, we found a direct correlation between
the degree of normality and the overall Gata2 expression levels, with
the most normal looking rescue embryos also expressing higher
Gata2 levels (corresponding to both endogenous and transgene
transcripts). qRT-PCR experiments on the yolk sacs of Actb2/2
R26+hGata2EpoR-iCre/+ embryos demonstrate that the rescue
embryos displaying higher Gata2 values (Figure 7A–C, light-grey
bars) also have higher Gata1, Hbb-y and Hbb-bh1 expression levels
at both E10.25 and E11.5 (Figure 7A,C). Gata2 target genes show
variable expression profiles in the rescue embryos (Figure 7B).
Interestingly, expression levels of gamma-actin did not decrease in
the rescue embryos at E10.25 (Figure 7B) and at E11.5 (data not
shown).
Discussion
This study has revealed an unexpected role for beta-actin
during development. Beta-actin has been described in protrusive
cellular structures and has traditionally been associated with a
major role in cell migration [6,8,38]. The Actb2/2 embryos appear
normal until E8.5 and they undergo gastrulation without any
obvious defects. Cell migration processes at these developmental
stages therefore seem to be intact. We investigated other events
requiring cell migration processes such as formation of the
vasculature and hematopoietic system in the embryo. PECAM-1
staining suggests some vessel disorganization in the embryo proper
and we also found vascular defects in the yolk sac. This could
indicate a cell migration defect of hemangioblast cells, a progenitor
population with both hematopoietic and vascular potential. These
cells are thought to migrate from the embryo proper to the blood
islands in the yolk sac where cells differentiate into primitive
erythrocytes and endothelial cells. However, by tracking heman-
gioblast cells expressing LacZ under the Flk1 promotor [39,40], we
observed no dramatic block in migration of hemangioblast cells at
E9.5. This strongly suggests that a cell migration problem of
hemangioblast cells per se is not causing the hematopoietic
problems in the embryo and consequently has no major
contribution to the observed lethality.
Our results however strongly suggest that an erythroid
differentiation defect is most likely responsible for the observed
embryonic lethality at E10.5 and one of the putative downstream
players involved is Gata2. Indeed, the expression of this key
erythroid transcription factor was dramatically downregulated at
E8.5. Similar to the Actb2/2 embryos in this study, Gata2 knockout
embryos show marked anemia and fail to survive beyond the stage
of primitive hematopoiesis [41]. Transgenic expression of Gata2
specifically in erythroid cells rescued the embryos from lethality at
E10.5. The Actb2/2 R26+hGata2EpoR-iCre/+ embryos displayed
obvious remodeled RBC containing blood vessels in the yolk sac
and embryo proper and the slight variations amongst those
embryos could be correlated with the levels of transgenic Gata2
expression. After rescue the Actb2/2 R26+hGata2EpoR-iCre/+
embryos displayed similar levels of embryonic hemoglobins
Hbb-y and Hbb-bh1, in line with restoration of primitive
erythropoiesis. The vasculature of yolk sac and embryo proper
appears intact at E11.5 in Actb2/2 R26+hGata2EpoR-iCre/+
embryos. This highly suggests that the vascular malformations
observed in the Actb2/2 embryo proper immediately before
lethality and the vascular remodeling defects in the yolk sac from
E9.5 onwards are secondary defects, whereas downregulation of
Gata2 and the associated block in primitive erythropoiesis is the
primary defect causing the observed lethality at E10.5. The lack of
full genetic rescue by erythroid-restricted GATA2 transgene
expression could imply important roles of Gata2 in later stages of
cardiovascular development [42,43] that are not rescued using this
approach.
One scenario whereby absence of beta-actin leads to reduced
Gata2 mRNA levels is that Gata2 expression is modulated by beta-
actin in the nucleus. The nuclear role of beta-actin has recently
been consolidated and it appears to have a potent role in the
regulation of transcription and gene expression by various
molecular means [10,44,45]. Our ChIP analysis supports a
function of beta-actin in the nucleus since we detected beta-actin
binding to specific regions of the Gata2 promotor. One of the
amplicons that was picked up by the ChIP experiment partly
overlapped with a highly conserved region in the Gata2 promoter,
suggesting the presence of important regulatory sequences in this
region of the promoter. Indeed, the detailed analyses revealed
multiple consensus sites for transcription factors with known roles
in erythropoiesis and/or hematopoiesis. However, it is not clear
whether these transcription factors bind to the Gata2 promotor in
vivo nor is it evident from literature that they associate with the
beta-actin protein. It also remains to be clarified whether beta-
actin itself binds to the promotor as a transcription factor or
whether it is part of a transcriptional complex. However, taking
the previously described roles of beta-actin into account
[10,11,12,44,45], we favor the possibility whereby beta-actin
binds the promotor of Gata2 in complex with other proteins.
Gamma-actin is, together with beta-actin, one of the main actin
isoforms during embryonic development. It is approximately 2-
fold upregulated in the embryo proper and in MEFs isolated from
the Actb2/2 embryos [13]. We observed similar compensatory
mechanisms in Actb2/2 yolk sacs (Figure S1A–C). It remains to
be clarified whether such an upregulation also occurs in the
Actb2/2 erythroid precursors but in two independent studies
using Actb2/2 MEFs and T-cells, an upregulation of the other
cytoplasmic actin isoform has been observed [13,18]. Therefore, in
addition to beta-actin specific nuclear effects on Gata2 expression,
lack of cytoskeletal integrity which is important in erythrocytes,
cannot completely be excluded.
In summary, our results reveal a novel role for beta-actin in the
early phases of hematopoiesis. By fine-tuning Gata2 levels beta-
actin plays a role in primitive and definitive erythropoiesis in the
early mouse embryo. This was further demonstrated by transgenic
expression of Gata2 in the erythroid lineages, as rescue embryos
were able to pass the primitive erythropoiesis phase. The functions
of beta-actin described here seem very specific for this actin
isoform as increased expression of gamma-actin cannot rescue this
phenotype. As well, transgenic expression of Gata2 does not lead to
a normalization of gamma-actin expression levels and gamma-
actin appears not to associate with regions in the Gata2 promotor
that are, however, bound by beta-actin in ChIP experiments. This
study has therefore shed new light on novel specific functions of
the beta-actin isoform during mouse embryogenesis.
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Figure 6. Actb2/2 R26+hGata2EpoR-iCre/+ embryos remain viable at E11.5. (A) Schematic view of the breeding scheme used to generate
Gata2 expression in the erythroid lineage in Actb2/2 mice. (B) Pictures from freshly dissected embryos at developmental stages E10.5, E11.5 and
E12.5. Black crosses mark the absence of Actb2/2 embryos at stages E11.5 and E12.5. Note the presence of RBCs in the Actb2/2 R26+hGata2EpoR-
iCre/+ embryos. Statistics on embryo recovery in function of genotype are in Table S3. E10.5: 156magnification, E11.5: 126magnification; E12.5: 106
magnification. (C) Morphology variation of Actb2/2 R26+hGata2EpoR-iCre/+ embryos at E11.5. Aberrant looking Actb2/2 R26+hGata2EpoR-iCre/+
embryos (left panel) compared to normal looking Actb2/2 R26+hGata2EpoR-iCre/+ embryos (right panel), 126magnification. Embryos were imaged
on a Leica MS5 (Leica Microsystems) stereomicroscope. Digital images were acquired using a Leica camera.
doi:10.1371/journal.pone.0067855.g006
Absence of Beta-Actin Modulates Erythropoiesis
PLOS ONE | www.plosone.org 9 June 2013 | Volume 8 | Issue 6 | e67855
Absence of Beta-Actin Modulates Erythropoiesis
PLOS ONE | www.plosone.org 10 June 2013 | Volume 8 | Issue 6 | e67855
Supporting Information
Figure S1 Compensatory up regulation of gamma-actin
occurs in Actb2/2 yolk sacs. (A) Relative gamma-actin
mRNA levels measured by qRT-PCR in yolk sacs of E8.5 and
E10.25 embryos. Both embryonic stages show an approximately
two fold increase in gamma-actin expression. Bars represent mean
6SEM; **P,.01, ***P,.001. (B) Western Blot analysis of
gamma-actin protein level in yolk sacs of E8.5 embryos. A slight
increase of gamma-actin can be detected in Actb2/2 yolk sacs
versus Actb+/+ yolk sacs. (C) Western Blot analysis of gamma-
actin protein level in yolk sacs of E10.25 embryos. The increase of
gamma-actin protein level in Actb2/2 yolk sacs is more
pronounced. (D) Comparison of expression of mouse beta- and
gamma actin at gastrula and organogenesis stage, data are from
http://www.ncbi.nlm.nih.gov/unigene.
(TIFF)
Figure S2 Consensus sites possibly important for
erythropoiesis in amplicon 3 and 8. Detail analysis of the
large amplicon 3 (amplicon 3+ regions between amplicon 2–3 and
3–4) and amplicon 8 reveal multiple DNA consensus sites for
binding of transcription factors possible involved in erythropoiesis
in mouse.
(TIFF)
Table S1 Overview of the primer sets used in this study.
(TIFF)
Table S2 Overview of the primer sets used for the ChIP
analysis and gene location of the corresponding ampli-
con.
(TIFF)
Table S3 Percentages of surviving embryos. Mendelian
ratios are given in bold under the genotype.
(TIFF)
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